| Year |
Citation |
Score |
| 2023 |
Al Jamal I, Parquet M, Guiyedi K, Aoufouchi S, Le Guillou M, Rizzo D, Pollet J, Dupont M, Boulin M, Faumont N, Boutouil H, Jardin F, Ruminy P, El Hamel C, Lerat J, ... ... Feuillard J, et al. IgH 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IgH rearrangement in unmutated chronic lymphocytic leukemia. Haematologica. PMID 37496419 DOI: 10.3324/haematol.2023.282897 |
0.695 |
|
| 2023 |
Perani A, Bourthoumieu S, Rizzo D, Chauzeix J, Dauriat B, Turlure P, Girault S, Veyrune L, Roubinet M, Feuillard J, Yardin C, Gachard N. Hereditary predisposition to malignant myeloid hemopathies: Caution in use of saliva and guideline based on our experience. Frontiers in Oncology. 13: 1120829. PMID 36923434 DOI: 10.3389/fonc.2023.1120829 |
0.57 |
|
| 2023 |
Saliba J, Manseur C, Groult H, Akil H, Tannoury M, Troutaud D, Maugard T, Feuillard J, Arnaudin I, Jayat-Vignoles C. Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network. Marine Drugs. 21. PMID 36827173 DOI: 10.3390/md21020132 |
0.757 |
|
| 2021 |
Aitamer M, Akil H, Vignoles C, Branchaud M, Abraham J, Gachard N, Feuillard J, Jauberteau MO, Shirvani H, Troutaud D, Bentayeb H. CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles. British Journal of Cancer. PMID 34743199 DOI: 10.1038/s41416-021-01611-7 |
0.696 |
|
| 2021 |
Eluard B, Nuan-Aliman S, Faumont N, Collares D, Bordereaux D, Montagne A, Martins I, Cagnard N, Caly M, Taoui O, Lordello L, Lehmann-Che J, Tesson B, Martinez-Climent JA, Copie-Bergman C, ... ... Feuillard J, et al. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma. Blood. PMID 34232979 DOI: 10.1182/blood.2020010039 |
0.321 |
|
| 2021 |
Ouk C, Roland L, Gachard N, Poulain S, Oblet C, Rizzo D, Saintamand A, Lemasson Q, Carrion C, Thomas M, Balabanian K, Espéli M, Parrens M, Soubeyran I, Boulin M, ... ... Feuillard J, et al. Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells. Frontiers in Immunology. 12: 641692. PMID 34017329 DOI: 10.3389/fimmu.2021.641692 |
0.702 |
|
| 2021 |
Renosi F, Roggy A, Giguelay A, Soret L, Viailly PJ, Cheok M, Biichle S, Angelot-Delettre F, Asnafi V, Macintyre E, Geffroy S, Callanan M, Petrella T, Deconinck E, Daguindau E, ... ... Feuillard J, et al. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis. Blood Advances. 5: 1540-1551. PMID 33687433 DOI: 10.1182/bloodadvances.2020003359 |
0.315 |
|
| 2021 |
Gayet M, Leymarie V, Derouault P, Guérin E, Vaidié J, Pascal V, Boulin M, Dmytruk N, Chauzeix J, Trimoreau F, Gachard N, Feuillard J, Rizzo D. Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia. Cytometry. Part B, Clinical Cytometry. PMID 33634586 DOI: 10.1002/cyto.b.21995 |
0.675 |
|
| 2021 |
Bayda N, Tilloy V, Chaunavel A, Bahri R, Halabi MA, Feuillard J, Jaccard A, Ranger-Rogez S. Comprehensive Epstein-Barr Virus Transcriptome by RNA-Sequencing in Angioimmunoblastic T Cell Lymphoma (AITL) and Other Lymphomas. Cancers. 13. PMID 33557089 DOI: 10.3390/cancers13040610 |
0.321 |
|
| 2020 |
Chauzeix J, Pastoret C, Donaty L, Gachard N, Fest T, Feuillard J, Rizzo D. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia. International Journal of Laboratory Hematology. PMID 33325634 DOI: 10.1111/ijlh.13435 |
0.577 |
|
| 2019 |
Garnache-Ottou F, Vidal C, Biichlé S, Renosi F, Poret E, Pagadoy M, Desmarets M, Roggy A, Seilles E, Soret L, Schillinger F, Puyraimond S, Petrella T, Preudhomme C, Roumier C, ... ... Feuillard J, et al. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Advances. 3: 4238-4251. PMID 31869411 DOI: 10.1182/Bloodadvances.2019000647 |
0.383 |
|
| 2019 |
Auclair H, Ouk-Martin C, Roland L, Santa P, Al Mohamad H, Faumont N, Feuillard J, Jayat-Vignoles C. EBV Latency III-Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1-Dependent Manner. Journal of Immunology (Baltimore, Md. : 1950). PMID 31434708 DOI: 10.4049/Jimmunol.1801420 |
0.797 |
|
| 2019 |
Vincent-Fabert C, Roland L, Zimber-Strobl U, Feuillard J, Faumont N. Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma. Cell Communication and Signaling : Ccs. 17: 89. PMID 31382969 DOI: 10.1186/S12964-019-0391-X |
0.455 |
|
| 2019 |
Vincent-Fabert C, Soubeyran I, Velasco V, Parrens M, Jeannet R, Lereclus E, Gachard N, Feuillard J, Faumont N. Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells. Cellular & Molecular Immunology. PMID 30967638 DOI: 10.1038/S41423-019-0228-Y |
0.678 |
|
| 2019 |
Vincent-Fabert C, Saintamand A, David A, Alizadeh M, Boyer F, Arnaud N, Zimber-Strobl U, Feuillard J, Faumont N. Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice. Cellular & Molecular Immunology. PMID 30635651 DOI: 10.1038/S41423-018-0197-6 |
0.808 |
|
| 2019 |
Faumont N, Taoui O, Collares D, Jais J, Leroy K, Jardin F, Molina T, Baud V, Feuillard J. C-REL NF-KAPPA B SUBUNIT ACTIVITY REFINES A DISTINCT GERMINAL CENTER DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUP WITH FAVORABLE OUTCOME Hemasphere. 3: 212-213. DOI: 10.1097/02014419-201906001-00418 |
0.305 |
|
| 2019 |
Chauzeix J, Pastoret C, Donaty L, Gachard N, Fest T, Feuillard J, Rizzo D. TUMOR MUTATIONAL BURDEN ASSESSED BY TARGETED HIGH THROUGHPUT SEQUENCING PREDICTS TREATMENT FREE SURVIVAL IN CLL: RESULTS FROM A BICENTER STUDY Hemasphere. 3: 515-516. DOI: 10.1097/01.HS9.0000562836.24474.FE |
0.557 |
|
| 2018 |
Carrion C, Guérin E, Gachard N, le Guyader A, Giraut S, Feuillard J. Adult Bone Marrow Three-Dimensional Phenotypic Landscape of B-Cell Differentiation. Cytometry. Part B, Clinical Cytometry. PMID 30450798 DOI: 10.1002/Cyto.B.21747 |
0.669 |
|
| 2018 |
Lamaa D, Lin HP, Zig L, Bauvais C, Bollot G, Bignon J, Levaique H, Pamlard O, Dubois J, Ouaissi M, Souce M, Kasselouri A, Saller F, Borgel D, Jayat-Vignoles C, ... ... Feuillard J, et al. Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on isocombretastatin A-4. Journal of Medicinal Chemistry. PMID 30004697 DOI: 10.1021/Acs.Jmedchem.8B00050 |
0.714 |
|
| 2018 |
Chauzeix J, Laforêt MP, Deveza M, Crowther L, Marcellaud E, Derouault P, Lia AS, Boyer F, Bargues N, Olombel G, Jaccard A, Feuillard J, Gachard N, Rizzo D. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients. Cancer Medicine. PMID 29745034 DOI: 10.1002/Cam4.1510 |
0.62 |
|
| 2017 |
Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe A, Dumezy F, Feuillard J, Geneviève F, Guérin E, Guy J, Jouault H, Lepelley P, Maynadié M, Solly F, Ballon OW, et al. Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia. Hematological Oncology. PMID 29218734 DOI: 10.1002/Hon.2488 |
0.304 |
|
| 2017 |
Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Laforet MP, Beylot-Barry M, Vergier B, Parrens M, Feuillard J, Merlio JP, Gachard N. Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type. Journal of Dermatological Science. PMID 28838616 DOI: 10.1016/J.Jdermsci.2017.07.008 |
0.697 |
|
| 2017 |
David A, Arnaud N, Fradet M, Lascaux H, Ouk-Martin C, Gachard N, Zimber-Strobl U, Feuillard J, Faumont N. C-Myc dysregulation is a co-transforming event for NF-κB activated B-cells. Haematologica. PMID 28232371 DOI: 10.3324/Haematol.2016.156281 |
0.833 |
|
| 2017 |
Rizzo D, Viailly PJ, Mareschal S, Bohers E, Picquenot JM, Penther D, Dubois S, Marchand V, Bertrand P, Maingonnat C, Etancelin P, Feuillard J, Bastard C, Tilly H, Jardin F, et al. Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas. American Journal of Hematology. 92: 68-76. PMID 27737507 DOI: 10.1002/Ajh.24584 |
0.347 |
|
| 2016 |
Troadec E, Dobbelstein S, Bertrand P, Faumont N, Trimoreau F, Touati M, Chauzeix J, Petit B, Bordessoule D, Feuillard J, Bastard C, Gachard N. A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: Toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3? Leukemia. PMID 27795560 DOI: 10.1038/Leu.2016.304 |
0.751 |
|
| 2016 |
Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, Orfao A, Moshaver B, Eidenschink Brodersen L, Loken MR, Wells DA, Subira' D, Cullen M, Te Marvelde JG, Van der Velden VH, ... ... Feuillard J, et al. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group. Haematologica. PMID 27758818 DOI: 10.3324/Haematol.2016.147835 |
0.311 |
|
| 2016 |
Halabi MA, Jaccard A, Moulinas R, Bahri R, Al Mouhammad H, Mammari N, Feuillard J, Ranger-Rogez S. Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment. International Journal of Cancer. 139: 793-802. PMID 27061907 DOI: 10.1002/Ijc.30128 |
0.331 |
|
| 2015 |
Rizzo D, Chauzeix J, Trimoreau F, Woillard JB, Genevieve F, Bouvier A, Labrousse J, Poli C, Guerin E, Dmytruk N, Remenieras L, Feuillard J, Gachard N. IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events. Leukemia. 29: 337-45. PMID 24943833 DOI: 10.1038/Leu.2014.198 |
0.623 |
|
| 2015 |
Poret E, Angelot Delettre F, Biichle S, Roogy A, Benazet L, Pagadoy M, Vidal C, Leroux F, Harrivel V, Ferrand C, Salaun V, Benseddik Z, Guy J, Jacob MC, Roumier C, ... Feuillard J, et al. Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN Blood. 126: 3812-3812. DOI: 10.1182/Blood.V126.23.3812.3812 |
0.387 |
|
| 2014 |
Farhat M, Poissonnier A, Hamze A, Ouk-Martin C, Brion JD, Alami M, Feuillard J, Jayat-Vignoles C. Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases Cell Death and Disease. 5. PMID 24787013 DOI: 10.1038/Cddis.2014.150 |
0.4 |
|
| 2014 |
Descatoire M, Weller S, Irtan S, Sarnacki S, Feuillard J, Storck S, Guiochon-Mantel A, Bouligand J, Morali A, Cohen J, Jacquemin E, Iascone M, Bole-Feysot C, Cagnard N, Weill JC, et al. Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties. The Journal of Experimental Medicine. 211: 987-1000. PMID 24733829 DOI: 10.1084/jem.20132203 |
0.372 |
|
| 2014 |
Chanut A, Duguet F, Marfak A, David A, Petit B, Parrens M, Durand-Panteix S, Boulin-Deveza M, Gachard N, Youlyouz-Marfak I, Bordessoule D, Feuillard J, Faumont N. RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells. Leukemia. 28: 871-9. PMID 24056880 DOI: 10.1038/Leu.2013.274 |
0.779 |
|
| 2014 |
Descatoire M, Weller S, Irtan S, Sarnacki S, Feuillard J, Storck S, Guiochon-Mantel A, Bouligand J, Morali A, Cohen J, Jacquemin E, Iascone M, Bole-Feysot C, Cagnard N, Weill J, et al. Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties Journal of Experimental Medicine. 211: 1005-1005. DOI: 10.1084/Jem.2013220304222014C |
0.475 |
|
| 2014 |
Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Beylot-Barry M, Vergier B, Parrens M, Merlio J, Feuillard J, Gachard N. La cellule d’origine du lymphome cutané B diffus à grandes cellules de type jambe : un lymphocyte B mature, post centre germinatif Annales De Dermatologie Et De VéNéRéOlogie. 141: S391. DOI: 10.1016/J.Annder.2014.09.369 |
0.614 |
|
| 2013 |
Rizzo D, Lotay A, Gachard N, Marfak I, Faucher JL, Trimoreau F, Guérin E, Bordessoule D, Jaccard A, Feuillard J. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival. American Journal of Hematology. 88: 747-53. PMID 23733486 DOI: 10.1002/Ajh.23494 |
0.698 |
|
| 2013 |
Laforêt MP, Turlure P, Lippert E, Cornillet-Lefebvre P, Pigneux A, Pradeau R, Feuillard J, Gachard N. Design and feasibility of a novel, rapid, and simple fluorescence 26-plex RT-PCR assay for simultaneous detection of 24 fusion transcripts in adult acute myeloid leukemia Journal of Molecular Diagnostics. 15: 186-195. PMID 23318495 DOI: 10.1016/J.Jmoldx.2012.11.004 |
0.611 |
|
| 2013 |
Rizzo D, Bouvier G, Youlyouz-Marfak I, Guerin E, Trimoreau F, Bordessoule D, Jaccard A, Gachard N, Feuillard J. T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells. Cytometry. Part B, Clinical Cytometry. 84: 125-32. PMID 23225571 DOI: 10.1002/Cyto.B.21055 |
0.701 |
|
| 2013 |
Lacombe F, Allou K, Arnoulet C, Campos L, de Labarthe A, Dumezy F, Feuillard J, Genevieve F, Guerin E, Guy J, Jouault H, Lepelley P, Maynadie M, Solly F, Ballon OW, et al. Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry Blood. 122: 2613-2613. DOI: 10.1182/Blood.V122.21.2613.2613 |
0.332 |
|
| 2012 |
Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, ... ... Feuillard J, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 27: 183-9. PMID 22944768 DOI: 10.1038/Leu.2012.257 |
0.63 |
|
| 2012 |
Durand-Panteix S, Farhat M, Youlyouz-Marfak I, Rouaud P, Ouk-Martin C, David A, Faumont N, Feuillard J, Jayat-Vignoles C. B7-H1, which represses EBV-immortalized B cell killing by autologous T and NK cells, is oppositely regulated by c-Myc and EBV latency III program at both mRNA and secretory lysosome levels. Journal of Immunology (Baltimore, Md. : 1950). 189: 181-90. PMID 22661084 DOI: 10.4049/Jimmunol.1102277 |
0.786 |
|
| 2012 |
Ndour PA, Brocqueville G, Ouk TS, Goormachtigh G, Morales O, Mougel A, Bertout J, Melnyk O, Fafeur V, Feuillard J, Coll J, Adriaenssens E. Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells. Journal of Virology. 86: 3934-43. PMID 22258264 DOI: 10.1128/Jvi.05747-11 |
0.712 |
|
| 2011 |
Durrieu F, Geneviève F, Arnoulet C, Brumpt C, Capiod JC, Degenne M, Feuillard J, Garand R, Kara-Terki A, Kulhein E, Maynadié M, Ochoa-Noguera ME, Plesa A, Roussel M, Eghbali H, et al. Normal levels of peripheral CD19 +CD5 + CLL-like cells: Toward a defined threshold for CLL follow-up-A GEIL-GOELAMS study Cytometry Part B - Clinical Cytometry. 80: 346-353. PMID 21976156 DOI: 10.1002/Cyto.B.20613 |
0.373 |
|
| 2011 |
Ouk C, Jayat-Vignoles C, Donnard M, Feuillard J. Both CD62 and CD162 antibodies prevent formation of CD36-dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells: a study with ImageStream®. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 79: 477-84. PMID 21462306 DOI: 10.1002/Cyto.A.21050 |
0.736 |
|
| 2011 |
Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C, Ysebaert L, Devidas A, Petit B, de Leval L, Gaulard P, Feuillard J, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 117: 1834-9. PMID 21123825 DOI: 10.1182/Blood-2010-09-307454 |
0.652 |
|
| 2011 |
Faure GC, Amsellem S, Arnoulet C, Bardet V, Campos L, De Carvalho-Bittencourt M, de Labarthe A, Eischen A, Feuillard J, Fossat C, Ottou FG, Guérin E, Guy J, Jouault H, Kuhlein E, et al. Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010. Immunology Letters. 134: 145-9. PMID 20951742 DOI: 10.1016/J.Imlet.2010.10.008 |
0.361 |
|
| 2011 |
Alamome I, Feuillard J, Faumont N. NF-κB Independent Protection Against Apoptosis by Overexpression of A20 in B-Cells Blood. 118: 5233-5233. DOI: 10.1182/Blood.V118.21.5233.5233 |
0.363 |
|
| 2011 |
Trimoreau F, Gachard N, Leymarie V, Frébet E, Perroud P, Feuillard J. Étapes préanalytiques pour la numération et cytologie sanguine Emc - Biologie MéDicale. 6: 1-10. DOI: 10.1016/S2211-9698(11)71443-1 |
0.549 |
|
| 2011 |
Trimoreau F, Guérin E, Gachard N, Leymarie V, Faucher J, Feuillard J, Béné M. Étapes préanalytiques pour la cytométrie en flux appliquée aux hémopathies Emc - Biologie MéDicale. 6: 1-6. DOI: 10.1016/S2211-9698(11)71442-X |
0.543 |
|
| 2011 |
Trimoreau F, Gachard N, Vrain A, Leymarie V, Perroud P, Feuillard J. Étapes préanalytiques pour la cytologie médullaire, ganglionnaire et des liquides biologiques Emc - Biologie MéDicale. 6: 1-8. DOI: 10.1016/S2211-9698(11)71441-8 |
0.544 |
|
| 2011 |
Gourin M, Gachard N, Trimoreau F, Abraham J, Moreau S, Mallissein E, Touati M, Feuillard J, Bordessoule D. 148 Myelodysplastic syndrome in very elderly patients: practice in the real life. Preliminary results on a monocentric cohort Leukemia Research. 35: S58. DOI: 10.1016/S0145-2126(11)70150-3 |
0.582 |
|
| 2011 |
Ouk-Martin C, Guérin E, Gourin M, Jayat-Vignoles C, Faucher J, Le Guyader A, Trimoreau F, Bordessoule D, Feuillard J. 115 ImageStream* quantitative analysis of cytomorphological and immunophenotypic erythroid cell lineage dyplasia in myelodysplastic syndromes Leukemia Research. 35: S44. DOI: 10.1016/S0145-2126(11)70117-5 |
0.749 |
|
| 2010 |
Richard Y, Amiel C, Jeantils V, Mestivier D, Portier A, Dhello G, Feuillard J, Creidy R, Nicolas JC, Raphael M. Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy. The Journal of Infectious Diseases. 202: 1424-34. PMID 20874514 DOI: 10.1086/656479 |
0.442 |
|
| 2010 |
Troutaud D, Petit B, Bellanger C, Marin B, Gourin-Chaury MP, Petit D, Olivrie A, Feuillard J, Jauberteau MO, Bordessoule D. Prognostic significance of BAD and AIF apoptotic pathways in diffuse large B-cell lymphoma. Clinical Lymphoma, Myeloma & Leukemia. 10: 118-24. PMID 20371444 DOI: 10.3816/Clml.2010.N.016 |
0.437 |
|
| 2010 |
Ndour PA, Ouk TS, Brocqueville G, Mougel A, Vanhecke E, Feuillard J, Coll J, Adriaenssens E. Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1. Cellular Signalling. 22: 303-13. PMID 19796681 DOI: 10.1016/J.Cellsig.2009.09.037 |
0.668 |
|
| 2010 |
Touati M, Gourin M, Abraham J, Weinbreck N, Gachard N, Olivrie-Gamaury A, Feuillard J, Jaccard A, Bordessoule D. Epidemiological review of lymphoma diagnosis in a French rural area between 2003 and 2008. Journal of Clinical Oncology. 28: e18551-e18551. DOI: 10.1200/Jco.2010.28.15_Suppl.E18551 |
0.631 |
|
| 2010 |
Gourin M, Turlure P, Gachard N, Girault S, Touati M, Abraham J, Philippon C, Feuillard J, Bordessoule D. Increased of overall survival (OS) and malignancies (K) during tyrosine kinase inhibitors (TKI) in a real life cohort of patients (pts) with a chronic myeloid leukemia (CML). Journal of Clinical Oncology. 28: 6602-6602. DOI: 10.1200/Jco.2010.28.15_Suppl.6602 |
0.601 |
|
| 2010 |
Chanut A, Durand-Panteix S, Weinbreck N, Youlyouz-Marfak I, Bordessoule D, Feuillard J, Faumont N. R17: Fonction et poids différentiel des complexes NF-kappaB contenant RelA ou RelB dans les lymphocytes B transformés par le virus d’Epstein-Barr et dans les lymphomes B diffus à grandes cellules de type activé Bulletin Du Cancer. 97: S22-S23. DOI: 10.1016/S0007-4551(15)30934-6 |
0.784 |
|
| 2010 |
Durand-Panteix S, Rouraud P, David A, Faumont N, Feuillard J, Jayat-Vignoles C. R16: Régulation de l’expression de l’immuno-inhibiteur B7-H1 dans les cellules B infectées par le virus d’Epstein-Barr Bulletin Du Cancer. 97: S22. DOI: 10.1016/S0007-4551(15)30933-4 |
0.779 |
|
| 2010 |
David A, Feuillard J, Faumont N. R12: Coopération entre c-Myc et le programme de latence III du virus d’Epstein-Barr dans la prolifération : rôle de NF-kappaB ? Bulletin Du Cancer. 97: S21. DOI: 10.1016/S0007-4551(15)30929-2 |
0.762 |
|
| 2009 |
van de Loosdrecht AA, Alhan C, Béné MC, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, Te Marvelde JG, et al. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica. 94: 1124-34. PMID 19546437 DOI: 10.3324/Haematol.2009.005801 |
0.326 |
|
| 2009 |
Faumont N, Le Clorennec C, Teira P, Goormachtigh G, Coll J, Canitrot Y, Cazaux C, Hoffmann JS, Brousset P, Delsol G, Feuillard J, Meggetto F. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway. Cancer Research. 69: 5177-85. PMID 19491276 DOI: 10.1158/0008-5472.Can-08-2866 |
0.811 |
|
| 2009 |
Petit B, Parrens M, Soubeyran I, Costes-Martineau V, Gachard N, Boulin M, Laurent C, Marfak A, Labrousse F, Bordessoule D, Feuillard J. Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern. Histopathology. 54: 626-31. PMID 19413643 DOI: 10.1111/J.1365-2559.2009.03262.X |
0.665 |
|
| 2009 |
Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadié M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. British Journal of Haematology. 145: 624-36. PMID 19388928 DOI: 10.1111/J.1365-2141.2009.07679.X |
0.352 |
|
| 2009 |
Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J. c-Myc and Rel/NF-κB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells Journal of Virology. 83: 5014-5027. PMID 19264782 DOI: 10.1128/Jvi.02264-08 |
0.806 |
|
| 2009 |
Faumont N, Chanut A, Benard A, Cogne N, Delsol G, Feuillard J, Meggetto F. Comparative analysis of oncogenic properties and nuclear factor-kB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes Haematologica. 94: 355-363. PMID 19211641 DOI: 10.3324/Haematol.13269 |
0.824 |
|
| 2009 |
Turlure P, Gachard N, Gourin M, Girault S, Touati M, Remenieras L, Moreau S, Philippon C, Lefort S, Feuillard J, Bordessoule D. Improved Survival in Recent Years of Chronic Myeloid Leukemia (CML) Observed in the Real World in a Cohort of Patients Cared in a Haematological Regional Network HEMATOLIM. Blood. 114: 4283-4283. DOI: 10.1182/Blood.V114.22.4283.4283 |
0.604 |
|
| 2009 |
Gourin M, Trimoreau F, Gachard N, Faucher J, Abraham J, Dmytruk N, Moreau S, Lamarche F, Girault S, Turlure P, Feuillard J, Bordessoule D. Is It Relevant to Determine Routinely Levels of Circulating NK and NK Like Cells in Myelodyplastic Syndroms?. Blood. 114: 2786-2786. DOI: 10.1182/Blood.V114.22.2786.2786 |
0.651 |
|
| 2008 |
Najjar I, Schischmanoff PO, Baran-Marszak F, Deglesne PA, Youlyouz-Marfak I, Pampin M, Feuillard J, Bornkamm GW, Chelbi-Alix MK, Fagard R. Novel function of STAT1beta in B cells: induction of cell death by a mechanism different from that of STAT1alpha. Journal of Leukocyte Biology. 84: 1604-12. PMID 18753311 DOI: 10.1189/Jlb.0508287 |
0.455 |
|
| 2008 |
Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis. Journal of Virology. 82: 6721-33. PMID 18448526 DOI: 10.1128/Jvi.02250-07 |
0.791 |
|
| 2008 |
Parrens M, Gachard N, Petit B, Marfak A, Troadec E, Bouabdhalla K, Milpied N, Merlio JP, de Mascarel A, Laurent C, Soubeyran I, Coste V, Labrousse F, Cogné M, Feuillard J. Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories. Leukemia. 22: 1621-4. PMID 18305562 DOI: 10.1038/Leu.2008.24 |
0.801 |
|
| 2008 |
Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC, et al. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica. 93: 215-23. PMID 18223290 DOI: 10.3324/Haematol.11622 |
0.692 |
|
| 2008 |
Jaccard A, Gachard N, Coppo P, Morschhauser F, Galicier L, Ysebaert L, Lenain P, Corront B, Suarez F, Feuillard J, Gaulard P, Bordessoule D, Hermine O. A Prospective Phase II Trial of An L-Asparaginase Containing Regimen in Patients with Refractory or Relapsing Extra Nodal NK/T-Cell Lymphoma Blood. 112: 579-579. DOI: 10.1182/Blood.V112.11.579.579 |
0.641 |
|
| 2008 |
Venkatachalam V, Martin CC, Jayat-Vignoles C, Faucher J, Feuillard J, Morrissey P, George T. Automated Classification of Normal and Leukemic B Cells on the ImageStream® Imaging Flow Cytometer Using Immunocytomorphological Image Characteristics Blood. 112: 4883-4883. DOI: 10.1182/Blood.V112.11.4883.4883 |
0.771 |
|
| 2008 |
Martin CC, Jayat-Vignoles C, Faucher J, George T, Venkatachalam V, Morrissey P, Feuillard J. Novel Multiparametric Quantitative Immunocytomorphological Characterisation of Human Bone Marrow Precursor Differentiation and of Haematopoietic Neoplasms Using ImageStream® Cytometry Blood. 112: 4871-4871. DOI: 10.1182/Blood.V112.11.4871.4871 |
0.776 |
|
| 2007 |
Youlyouz-Marfak I, Gachard N, Le Clorennec C, Najjar I, Baran-Marszak F, Reminieras L, May E, Bornkamm GW, Fagard R, Feuillard J. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death and Differentiation. 15: 376-85. PMID 17992189 DOI: 10.1038/Sj.Cdd.4402270 |
0.652 |
|
| 2007 |
Faucher JL, Lacronique-Gazaille C, Frébet E, Trimoreau F, Donnard M, Bordessoule D, Lacombe F, Feuillard J. "6 markers/5 colors" extended white blood cell differential by flow cytometry. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 71: 934-44. PMID 17879238 DOI: 10.1002/Cyto.A.20457 |
0.356 |
|
| 2007 |
Lacronique-Gazaille C, Chaury MP, Le Guyader A, Faucher JL, Bordessoule D, Feuillard J. A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML. Haematologica. 92: 859-60. PMID 17550865 DOI: 10.3324/Haematol.11118 |
0.304 |
|
| 2007 |
Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? British Journal of Haematology. 136: 539-48. PMID 17367408 DOI: 10.1111/J.1365-2141.2006.06458.X |
0.394 |
|
| 2007 |
Schlee M, Hölzel M, Bernard S, Mailhammer R, Schuhmacher M, Reschke J, Eick D, Marinkovic D, Wirth T, Rosenwald A, Staudt LM, Eilers M, Baran-Marszak F, Fagard R, Feuillard J, et al. c-MYC activation impairs the NF-κB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma International Journal of Cancer. 120: 1387-1395. PMID 17211884 DOI: 10.1002/Ijc.22372 |
0.438 |
|
| 2006 |
Goormachtigh G, Ouk TS, Mougel A, Tranchand-Bunel D, Masy E, Le Clorennec C, Feuillard J, Bornkamm GW, Auriault C, Manet E, Fafeur V, Adriaenssens E, Coll J. Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways. Journal of Virology. 80: 7382-93. PMID 16840319 DOI: 10.1128/Jvi.02052-05 |
0.793 |
|
| 2006 |
Baran-Marszak F, Laguillier C, Youlyouz I, Feuillard J, Mariette X, Fagard R, Raphaël M. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus. Cytokine. 33: 337-45. PMID 16713282 DOI: 10.1016/J.Cyto.2006.03.005 |
0.802 |
|
| 2006 |
Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, Feuillard J. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Blood. 107: 2070-8. PMID 16317104 DOI: 10.1182/Blood-2005-05-2053 |
0.819 |
|
| 2005 |
Bornkamm GW, Berens C, Kuklik-Roos C, Bechet JM, Laux G, Bachl J, Korndoerfer M, Schlee M, Hölzel M, Malamoussi A, Chapman RD, Nimmerjahn F, Mautner J, Hillen W, Bujard H, ... Feuillard J, et al. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Research. 33: e137. PMID 16147984 DOI: 10.1093/Nar/Gni137 |
0.319 |
|
| 2005 |
Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N, Perfettini JL, Djavaheri-Mergny M, Youlyouz-Marfak I, Codogno P, Raphael M, Feuillard J, Kroemer G. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene. 24: 7503-13. PMID 16091749 DOI: 10.1038/Sj.Onc.1208907 |
0.35 |
|
| 2005 |
Najjar I, Baran-Marszak F, Le Clorennec C, Laguillier C, Schischmanoff O, Youlyouz-Marfak I, Schlee M, Bornkamm GW, Raphaël M, Feuillard J, Fagard R. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells. Journal of Virology. 79: 4936-43. PMID 15795279 DOI: 10.1128/Jvi.79.8.4936-4943.2005 |
0.796 |
|
| 2005 |
Petit B, Chaury MP, Le Clorennec C, Jaccard A, Gachard N, Moalic-Judge S, Labrousse F, Cogné M, Bordessoule D, Feuillard J. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. Haematologica. 90: 200-6. PMID 15710572 |
0.801 |
|
| 2005 |
Youlyouz-Marfak I, Le Clorennec C, Najjar I, Baran-Marszak F, Gachard N, Remenieras L, Jaccard A, Bornkamm GW, Fagard R, Feuillard J. Antitumor Genotoxic Agents, Such as Fludarabine*, Doxorubincin or Cis-Platine, Induce Activation of STAT1 in a p53 Protein Dependent Manner. Blood. 106: 4384-4384. DOI: 10.1182/Blood.V106.11.4384.4384 |
0.675 |
|
| 2005 |
Garnache-Ottou F, Jacob M, Biichle S, Chaperot L, Trimoreau F, Plumas J, Tiberghien P, Saas P, Feuillard J. Identification of BDCA-2 and High Levels of CD123 Expression as Useful Markers for the Diagnosis of Plasmacytoid Dendritic Cell Leukemia. Blood. 106: 3269-3269. DOI: 10.1182/Blood.V106.11.3269.3269 |
0.387 |
|
| 2004 |
Baran-Marszak F, Feuillard J, Najjar I, Le Clorennec C, Béchet JM, Dusanter-Fourt I, Bornkamm GW, Raphaël M, Fagard R. Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood. 104: 2475-83. PMID 15217838 DOI: 10.1182/Blood-2003-10-3508 |
0.809 |
|
| 2004 |
Duval A, Raphael M, Brennetot C, Poirel H, Buhard O, Aubry A, Martin A, Krimi A, Leblond V, Gabarre J, Davi F, Charlotte F, Berger F, Gaidano G, Capello D, ... ... Feuillard J, et al. The mutator pathway is a feature of immunodeficiency-related lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 101: 5002-7. PMID 15047891 DOI: 10.1073/Pnas.0400945101 |
0.302 |
|
| 2004 |
Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bordessoule D, Bornkamm GW, Feuillard J. Regulation of CD95 in EBV infected B-Cells. Blood. 104: 81-81. DOI: 10.1182/Blood.V104.11.81.81 |
0.44 |
|
| 2004 |
Gachard N, Turlure P, Trimoreau F, Moreau S, Donnard M, Chaury M, Pradeau R, Bordessoule D, Feuillard J. Quantification of MDM2 Gene Expression Level by RQ-PCR Is Predictive of the First Complete Remission in Adulte Acute Myeloid Leukaemia. Blood. 104: 1068-1068. DOI: 10.1182/Blood.V104.11.1068.1068 |
0.636 |
|
| 2003 |
Le Guern V, Le Roux G, Martin A, Feuillard J, Cohen P, Poirel H, Raphaël M, Guillevin L, Mouthon L. Lymphoma complicating common variable immunodeficiency with granulomatous disease: report of two cases. European Journal of Haematology. 71: 459-63. PMID 14703697 DOI: 10.1046/J.0902-4441.2003.00082.X |
0.33 |
|
| 2003 |
Béné MC, Feuillard J, Jacob MC. Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies. Seminars in Hematology. 40: 257-66. PMID 12876674 DOI: 10.1016/S0037-1963(03)00139-2 |
0.379 |
|
| 2003 |
Touitou R, Arbach H, Cochet C, Feuillard J, Martin A, Raphaël M, Joab I. Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines. The Journal of General Virology. 84: 949-957. PMID 12655096 DOI: 10.1099/Vir.0.18687-0 |
0.413 |
|
| 2003 |
Trimoreau F, Donnard M, Turlure P, Gachard N, Bordessoule D, Feuillard J. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies. Haematologica. 88: ELT10. PMID 12651292 |
0.576 |
|
| 2002 |
Park S, Noguera ME, Brière J, Feuillard J, Cayuela JM, Sigaux F, Brice P. Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma. The Hematology Journal : the Official Journal of the European Haematology Association / Eha. 3: 317-20. PMID 12522456 DOI: 10.1038/Sj.Thj.6200202 |
0.431 |
|
| 2002 |
Baran-Marszak F, Fagard R, Girard B, Camilleri-Broët S, Zeng F, Lenoir GM, Raphaël M, Feuillard J. Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines. Laboratory Investigation; a Journal of Technical Methods and Pathology. 82: 1463-79. PMID 12429807 DOI: 10.1097/01.Lab.0000035025.51772.2B |
0.464 |
|
| 2002 |
Maynadié M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G, Campos L, Dromelet A, Lepelley P, Jouault H, Imbert M, Rosenwadj M, Vergé V, Bissières P, Raphaël M, ... ... Feuillard J, et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood. 100: 2349-56. PMID 12239142 DOI: 10.1182/Blood-2002-01-0230 |
0.324 |
|
| 2002 |
Fagard R, Mouas H, Dusanter-Fourt I, Devillers C, Bissières P, Martin A, Lenoir G, VanTan H, Feuillard J, Raphaël M. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. Oncogene. 21: 4473-80. PMID 12085225 DOI: 10.1038/Sj.Onc.1205554 |
0.512 |
|
| 2002 |
Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, Le Mée F, Plessis G, Talmant P, Gachard N, Uettwiller F, Pages MP, Mozziconacci MJ, Eclache V, Sibille C, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood. 99: 4154-9. PMID 12010820 DOI: 10.1182/Blood.V99.11.4154 |
0.642 |
|
| 2002 |
Feuillard J, Jacob MC, Valensi F, Maynadié M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drénou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 99: 1556-63. PMID 11861268 DOI: 10.1182/Blood.V99.5.1556 |
0.328 |
|
| 2001 |
McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, Debré P, Feuillard J, Hosmalin A. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 97: 3470-7. PMID 11369639 DOI: 10.1182/Blood.V97.11.3470 |
0.327 |
|
| 2001 |
Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Brière F, Plumas J, Jacob MC. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 97: 3210-7. PMID 11342451 DOI: 10.1182/Blood.V97.10.3210 |
0.417 |
|
| 2000 |
Feuillard J, Mémet S, Goudeau B, Lilienbaum A, Schmidt-Ullrich R, Raphaël M, Israël A. In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-κB/Rel complexes International Immunology. 12: 613-621. PMID 10784607 DOI: 10.1093/INTIMM/12.5.613 |
0.344 |
|
| 1999 |
El Mansouri S, Martin A, Mercadier A, Capoulade C, Maréchal V, Wiels J, Feuillard J, Raphaël M. High expression of MDM2 protein and low rate of p21(WAF1/CIP1) expression in SCID mice Epstein Barr virus-induced lymphoproliferation. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 1315-22. PMID 10490460 DOI: 10.1177/002215549904701011 |
0.319 |
|
| 1999 |
Joubert-Caron R, Feuillard J, Kohanna S, Poirier F, Le Caër JP, Schuhmacher M, Bornkamm GW, Polack A, Caron M, Bladier D, Raphaël M. A computer-assisted two-dimensional gel electrophoresis approach for studying the variations in protein expression related to an induced functional repression of NFkappaB in lymphoblastoid cell lines. Electrophoresis. 20: 1017-26. PMID 10344280 DOI: 10.1002/(Sici)1522-2683(19990101)20:4/5<1017::Aid-Elps1017>3.0.Co;2-K |
0.324 |
|
| 1999 |
Legendre C, Raphael M, Gras G, Lefevre EA, Feuillard J, Dormont D, Richard Y. CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients. International Immunology. 10: 1847-51. PMID 9885905 DOI: 10.1093/Intimm/10.12.1847 |
0.324 |
|
| 1998 |
Asso-Bonnet M, Feuillard J, Ferreira V, Bissières P, Tarantino N, Körner M, Raphael M. Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene. 17: 1607-15. PMID 9794238 DOI: 10.1038/Sj.Onc.1202365 |
0.449 |
|
| 1998 |
Asso-Bonnet M, Feuillard J, Ferreira V, El Mansouri S, Bissières P, Tarantino N, Körner M, Raphael M. RELATIONSHIPS BETWEEN I-KAPPA B ALPHA CONSTITUTIVE EXPRESSION, TNF ALPHA SYNTHESIS, CELL CYCLE AND APOPTOSIS IN EBV-INFECTED LYMPHOBLASTOID CELL LINE. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A35. DOI: 10.1097/00042560-199804010-00110 |
0.363 |
|
| 1997 |
Casamayor-Palleja M, Feuillard J, Ball J, Drew M, MacLennan IC. Centrocytes rapidly adopt a memory B cell phenotype on co-culture with autologous germinal centre T cell-enriched preparations. International Immunology. 8: 737-44. PMID 8671662 DOI: 10.1093/intimm/8.5.737 |
0.339 |
|
| 1996 |
Feuillard J, Körner M, Israel A, Vassy J, Raphael M. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ. European Journal of Immunology. 26: 2547-51. PMID 8921937 DOI: 10.1002/Eji.1830261102 |
0.407 |
|
| 1996 |
Benhamou M, Feuillard J, Lortholary O, Bourgeois C, Michel L, LeGoff L, Michel A, Mencia-Huerta JM, Lejeune F, Casassus P, Debré P, Arock M. Protein tyrosine kinases in activation signal of human basophils through the immunoglobulin E receptor type l. Journal of Leukocyte Biology. 59: 461-70. PMID 8604027 DOI: 10.1002/Jlb.59.3.461 |
0.308 |
|
| 1991 |
Feuillard J, Gouy H, Bismuth G, Lee LM, Debré P, Körner M. NF-kappa B activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases. Cytokine. 3: 257-65. PMID 1653056 DOI: 10.1016/1043-4666(91)90025-9 |
0.389 |
|
| Show low-probability matches. |